As with other NHEJ proteins, DNA-PKcs has long been considered a targetto sensitize tumor cells to radiation therapy, leading to the development of specificDNA-PKcs inhibitors such as DMNB and NU7026. The gene discussed is PRKDC; the disease is neoplasm.